【レポートの概要（一部）】
1. Report Overview
1.1 Biobanking for Medicine: World Market Review 2014
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by This Analysis
1.5 Who is This Study For?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain
2. Introduction to Biobanking and its Applications
2.1 The Human Tissue Banking Market – Our Definition
2.2 The Stem Cell Banking Market – Our Breakdown
2.3 What is Biobanking?
2.4 Main Features of Biobanks
2.5 What Processes are Involved in Biobanking?
2.6 Classification of Biobanks: Tissue Type, Volunteer Group and Ownership Classification Models
2.6.1 Volunteer Group: General vs. Disease Population
2.6.2 Ownership Structure: Public vs. Private
2.7 The Guidelines and Standards for Biobanking
2.8 Laws and Regulations for Biobank-Based Research
2.8.1 HIPAA Amendments
2.9 Biobanking and the Pharmaceutical Industry
2.9.1 Biobanking in Research, Drug Discovery and Development
2.9.1.1 Biobanking – Facilitates Genetic Epidemiology Studies
2.9.1.2 Novel Drug Discovery through Better Understanding of Disease Pathways
2.9.1.3 Biomarker Discovery in Drug Development
2.9.2 Biobanking for Therapeutic Purposes
2.9.3 Biobanking in Clinical Trials
3. Biobanking for Medicine: World Market 2015-2025
3.1 The World Biobanking for Medicine Market in 2014
3.2 Biobanking for Medicine: Research vs. Therapeutics in 2019 and 2025
3.3 World Biobanking for Medicine Market: Overarching Revenue Forecast 2015-2025
3.4 Biobanks Stored Around 1.3 Billion Specimens in 2014
3.5 The Biobanking for Medicine Market by Sector: Grouped Revenue Forecasts 2015-2025
3.6 Biobanking for Research: Mostly Non-Profit
3.6.1 Biobanking for Research: Revenue Forecast 2015-2025
3.6.2 Driving Forces Outweigh Restraints on the Biobanking Industry for Research
3.7 Biobanking for Future Therapeutic Use: Is It Too Commercial?
3.7.1 Arguments against Commercial Stem Cell Banking for Therapeutic Uses
3.7.2 Biobanking for Future Therapeutic Use: Revenue Forecast 2015-2025
3.7.3 Driving and Restraining Forces Influencing the Biobanking Market for Therapeutic Applications, 2015-2025
4. Biobanking for Research Purposes
4.1 Breakdown of the Biobanking for Research Market by Tissue Type, 2014
4.2 Biobanking for Research in 2019 and 2025: Comparison by Tissue Type
4.3 Biobanking for Research by Tissue Type: Grouped Revenue Forecasts 2015-2025
4.4 How Many Specimens are Biobanked for Research?
4.5 The Human Tissue Banking Market for Research in 2014
4.6 The Human Tissue Banking Market for Research: Revenue Forecast 2015-2025
4.7 The Human Tissue Banking Market: Commercial vs. Public Sector
4.7.1 Commercial Human Tissue Banks: Revenue Forecast 2015-2025
4.7.2 Public Sector Human Tissue Banks: Revenue Forecast 2015-2025
4.8 The Stem Cell Banking Market for Research in 2014
4.9 The Stem Cell Banking Market for Research: Revenue Forecast 2015-2025
4.9.1 R&D – Growing Interest towards iPSCs
4.10 Banking of Other Biologic Specimens for Research in 2014
4.11 Banking of Other Biologic Specimens for Research: Revenue Forecast 2015-2025
5. Stem Cell Banking for Future Therapeutic Use
5.1 Stem Cell Banking for Therapeutic Use in 2014: A Breakdown by Stem Cell Type
5.2 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Comparison of Revenue and Market Share, 2019 and 2025
5.3 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Grouped Revenue Forecasts
5.4 How Many Stem Cell Samples Are Biobanked Each Year?
5.5 The Umbilical Cord Blood Banking Market in 2014
5.5.1 Private vs. Public Cord Blood Banking
5.5.2 Umbilical Cord Blood Banking: The Controversies
5.6 The Umbilical Cord Blood Banking Market: Revenue Forecast 2015-2025
5.7 The Adult Stem Cell Banking Market in 2014
5.8 The Adult Stem Cell Banking Market: Revenue Forecast 2015-2025
6. Leading National Markets 2015-2025
6.1 The Geographical Footprint of Biobanking
6.1.1 Biobanking in Europe: Leading the World with Biobanking Networks and Infrastructure
6.1.2 Biobanks in the US: A Fragmented Picture
6.1.3 Biobanking in Asia: A Region Fast Gaining Prominence
6.2 Biobanking for Medicine: The US Led the Way in 2014
6.3 The Leading National Markets: Grouped Revenue Forecasts 2015-2025
6.4 How Will Regional Market Shares Change to 2025?
6.5 The US Biobanking Market 2014-2024: Diversifying and Expanding
6.6 The Top European Biobanking Markets 2015-2025: Leading the Way in Biobanking Infrastructure
6.6.1 Germany: An Advanced Industry with 74 Biobanks Associated with the BBMRI
6.6.2 France: Restrictions on Private Stem Cell Banking Limit the Market
6.6.3 Italy: Is the Limited Private Stem Cell Banking Market Off-Set by Strong Biobanking Networks for Research?
6.6.4 UK: Limited Presence of Biobanking Networks
6.6.5 Spain: Controversy Between Private and Public Umbilical Cord Blood Banks
6.6.6 The Netherlands is Characterised by Comprehensive Biobanking Networks
6.7 The Japanese Biobanking Market 2015-2025: A High Level of Government Investment Drives Growth
6.8 The Biobanking Industry in the BRIC Countries: High Growth and Increasing Market Share between 2015 and 2025
6.8.1 The Chinese Biobanking Market 2015-2025: The High Rate of Growth Will Continue
6.8.2 The Indian Biobanking Market 2015-2025: Set to Become the Leading Market for Private Stem Cell Banking?
6.8.3 The Brazilian Biobanking Market 2015-2025: Will New Regulations Drive or Restrain the Market?
6.8.4 Russia: Ban on the Import and Export of Human Tissue and Genetic Information Restricts the Market, But Can This Be Overcome from 2015-2025?
7. Technology for Biobanking: Systems, Software, Consumables and Services Associated With Biobanking
7.1 The Biobanking-Associated Market: Overview
7.2 Systems Technology: Fully Automated Handling
7.2.1 Automated Liquid Handling Systems
7.2.2 Frozen Aliquoting: Patented Technology from CryoXtract
7.2.3 Automated DNA Isolation
7.3 Storage Technology: Sustainability and Easy Sample Tracking
7.3.1 Dry State, Room Temperature Storage Eliminates the Need for Expensive, Energy-Consuming Freezers
7.3.2 Ultra-Low Temperature Freezers: Is Their Use Declining?
7.3.3 Cryopreservation: Mechanical vs. Liquid/ Vapour Phase Nitrogen
7.3.4 Automated Storage and Retrieval Systems: Essential Technology
7.3.5 RFID and Tagging Technology: Advantages over Barcodes
7.4 Software for Biobanks
7.4.1 Laboratory Information Management System (LIMS): Unmet Needs in the Market Remain, Despite Recent Advances
7.4.2 LIMS Functions
7.5 Consumables: High Quality Required for Effective Sample Management
7.5.1 Addressing Sample Storage and Tracking Issues
7.6 Biobanking Services: Storage, Management and Transport of Biologic Samples for a Fee
8. Leading Companies in the Biobanking Market
8.1 The Differing Business Models of Biobanking Companies: Sourcing vs. Storing
8.2 Commercial Biobanks for Research Purposes in 2014
8.2.1 Tissue Solutions: A Virtual Biobank with a Global Presence
8.2.1.1 An Overview of the Products and Services Offered by Tissue Solutions
8.2.1.2 Banked Samples Occur in Many Formats
8.2.1.3 Prospective Tissue Collection for Hard-to-Find Samples
8.2.1.4 Fresh Samples from Surgical Resections are in High Demand
8.2.1.5 Freshly Isolated Human Cells are a Valuable Research Tool
8.2.1.6 FDA/ EMA Panel of Normal Tissues
8.2.1.7 Strengths, Capabilities and the Future Outlook for Tissue Solutions
8.2.2 Asterand is now Part of Stemgent
8.2.2.1 Asterand’s Products and Services: XpressBANK, ProCURE and PhaseZERO
8.2.3 Biopta Provides Fresh Human Tissues, for Which Demand is Growing
8.2.3.1 Services from Biopta: Fresh Tissue Sample Procurement and a Variety of Lab Services
8.2.3.2 The First Catalogue of Assays Based on Human Functional Tissues
8.2.3.3 The Future Outlook for Biopta
8.2.4 BioServe: One of the World’s Largest Commercial Biorepositories
8.2.4.1 BioServe Offers a Comprehensive List of Services: Biobanking, Sourcing and Preclinical Molecular Services
8.2.4.2 The Future Outlook for BioServe
8.2.5 Coriell Institute for Medical Research: Reportedly the Largest Biobank in the World
8.2.5.1 Features of Coriell Biobank
8.2.5.2 Future Outlook for the Coriell Biobank
8.3 Prominent Biobanks for Therapeutic Use in 2014
8.3.1 Cord Blood America: Expansion into the Emerging Markets Apparently Stalled
8.3.2 Cryo-Cell International: The First Private Cord Blood Bank in the Market
8.3.3 Cryo-Save’s Educational Programme Benefits Company’s Growth
8.3.4 China Cord Blood Corp: The Only Cord Blood Bank in China with Multiple Licences
8.3.5 LifebankUSA: Placental and Cord Blood Banking Means a Significant Survival Advantage in Transplant Patients
8.3.6 ViaCord: More Blood Units Released for Therapy than Any Other Family Bank
8.3.7 Cord Blood Registry: The World’s Largest Newborn Stem Cell Company, Accounting for 3% of the Private Stem Cell Banking Industry
8.3.8 Biogenea Pharmaceuticals: A Comprehensive Offering of Stem Cell Banking Services across the Balkan Peninsula
8.3.9 StemLife is Facing Challenges due to Government Regulations in Malaysia
8.3.10 Future Health Biobank: A Strong Market Presence Owing to International Operations
8.3.11 NeoStem Operates a Multi-Faceted Business Strategy
8.3.12 Precious Cells is Well Positioned to Take Advantage of the Growing Demand in India
9. Qualitative Analysis of the Biobanking Industry and Market 2015-2025
9.1 Industry Trends
9.1.1 The Growing Demand for Biobank Resources for Research
9.1.2 The Establishment of Biobanking Networks
9.1.2.1 BBMRI: The Most Extensive Biobank Network
9.1.3 Virtual Biobanks: Connecting a Fragmented Industry
9.1.4 Commercial Biobanks as Intermediaries: New Resources for Research
9.1.5 Automated Biobanking Has Become Imperative
9.1.6 Increasing Uptake of LIMS
9.1.7 Green Banking – Becoming More Energy Efficient
9.2 The Strengths and Weaknesses of the Biobanking Market in 2014
9.2.1 HBS are Valuable Resources for R&D
9.2.2 Governmental Support for Biobanking Forms a Strength of that Industry
9.2.3 Development of Potential Novel Stem Cell Therapies has Increased Public Awareness of Stem Cell Banking
9.2.4 Insufficient Accessible Numbers of High Quality Biospecimens
9.2.5 Biobanks are Fragmented and Uncoordinated
9.2.6 Lack of Standardisation is a Weakness of the Industry
9.2.7 Lack of Public Awareness Limits Number of Donors
9.2.8 Lack of Engagement with Public Health Services Limits the Stem Cell Banking Market
9.3 Opportunities and Threats Facing the Biobanking Market, 2015-2025
9.3.1 Increasing Use of Biobanked Specimens in Genome-Wide Association Studies (GWAS)
9.3.2 Increasing Demand for Biobanked Samples for Preclinical Research
9.3.3 Biobanking Networks as a Basis for Personalised Medicine
9.3.4 Options for Adult Stem Cell Banking Mean an Increasing Target Population for Private Stem Cell Banks
9.3.5 Even With Governmental Funding, Biobanks Must Become Self-Sufficient to Thrive Long Term
9.3.6 Public Concerns over Confidentiality and Security Threaten Availability of Donors
9.3.7 Limitations Surrounding Informed Consent
9.4 Social, Technological, Economic and Political Factors (STEP) Influencing the Biobanking Industry, 2015-2025
10. Research Interviews from Our Survey – 2015
10.1 Dr Jeanne-Hélène di Donato, 3C-R, France
10.1.1 French Biobanks – a Network of Specialized Biobanks
10.1.2 Biobanking Management –Promoting Scientific Value of Collections
10.1.3 Harmonization – Scientific Valorisation
10.1.4 Bioethical – Diverse Views and Policies on Consent
10.1.5 Broad Consent –Is This the Best Option?
10.1.6 3C-R – Services and Solutions for Biobanks
10.2 Dr Luis Nacul and Dr Eliana Lacerda, UK ME/CFS Biobank Project
10.2.1 UK ME/CFS Biobank – Objectives and Activities
10.2.2 Biobank Resource – Available for External Researchers in August 2015
10.2.3 Main Issue – Sustainability
10.2.4 Unmet Needs – Awareness from Government and General Public
11. Conclusions from the Research and Analysis
11.1 World Biobanking Market 2015-2025: High Revenue Growth Predicted
11.2 Biobanking for Research 2015-2025: The Value of Biobanked Specimens is Increasingly Recognised
11.3 Biobanking for Therapeutic Use 2015-2025: Rapid Expansion in Adult Stem Cell Banking
11.4 The Leading National Markets: High Sales Growth Worldwide
11.5 Current and Future Trends in Biobanking
11.5.1 Increasing Demand for Biobanked Samples – Increasing Revenue
11.5.2 Improving Biobanking Infrastructure – Growth Driver
11.5.3 Marked Challenges, but Opportunities for Expansion
【レポート販売概要】
■ タイトル：医療バイオバンクの世界市場：組織バンク、幹細胞バンク（臍帯血幹細胞バンク、成体幹細胞バンク）■ 英文：Biobanking for Medicine: Technology, Industry and Market 2015-2025
■ 発行日：2015年6月
■ 調査会社：visiongain
■ 商品コード：VGAIN50615
■ 調査対象地域：グローバル
- 世界の酸性調節装置市場Food acidulants form an integral part of the global food additives industry as these provide an acidic medium and flavor to food and beverage items. These regulate the acidity of the food and help to increase shelf life. These also prevent the microbial activity and play a major role in food preservation. This research report provides a comprehensive analysis of the global food acidulants market, …
- 水栓の世界市場2016-2020About Faucet A faucet is a sanitary-ware fitting that controls the flow of water from the pipe. The development of the retail industry worldwide has brought about significant changes in retail distribution with the emergence of a variety of distribution channels for sanitary-ware products. Bathrooms are becoming more eco-friendly, which saves water and gives facility to end-users. From cisterns to …
- 世界の軍事用電気光学・赤外線市場（2014-2024）：市場規模、動因Synopsis This report provides readers with a comprehensive analysis of the Military Electro Optical Infrared (EO/IR) market through 2013-2023, including highlights of the demand drivers and growth stimulators for Military Electro Optical Infrared (EO/IR). It also provides an insight on the spending pattern and modernization pattern in different regions around the world. Summary The global military …
- ケアマネジメントソリューションの世界市場予測（～2021）The care management solutions market is projected to reach USD 15.70 Billion by 2021 from USD 6.93 Billion in 2016, growing at a CAGR of 17.8%. Factors such as the implementation of initiatives to shift the burden of risk from payers to providers, legislations and initiatives to promote ‘patient-centeredness’ in healthcare, rising geriatric population coupled with the burden of chronic diseases, n …
- 一次電池の世界市場：アルカリ電池、リチウム電池About Primary Batteries Primary batteries need to be disposed after use as they are not non-rechargeable cells. Therefore, they are also known as throw-away. There are numerous advantages of primary batteries as well as numerous disadvantages. The disadvantages provide secondary batteries an edge over primary batteries in the market, which is the main reason of the rapid increase in the secondary …
- Coastal Energy Company：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Coastal Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Coastal Energy Company Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 家庭用空気清浄機の中国市場ABSTRACTAbout Residential Air Purifier Air purifiers, also known as air cleaners, are devices that absorb or decompose harmful air pollutants such as allergens, viruses, PM2.5 particles, odors, formaldehyde, and others. The market is segmented based on the technology that is used to purify the air. The technology segmentation includes HEPA and ULPA air purifiers, activated carbon air purifiers, ph …
- Statoil ASA：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Statoil ASA Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Statoil ASA Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational …
- 音声分析ソリューションの世界市場：スピーチエンジン、索引、分析・クエリーツール、ダッシュボード、レポートツールMarketsandMarkets forecasts the speech analytics market size to grow from USD 589.2 Million in 2015 to USD 1.60 Billion by 2020, at a Compound Annual Growth Rate (CAGR) of 22.0% from 2015 to 2020. Today, the multichannel world consists of voice, email, chat, social channels, and surveys, and each channel has its own importance. It has been observed that voice, phone interaction, is the most common …
- 世界の軍事弾薬市場動向2013-2023：主な開発プロジェクトThis report discusses the various programmes conducted by key players in the market, by dividing them into the main types of Military Ammunition. The report offers detailed information regarding quantity procured, country/companies supplying the equipment, delivery period and total contract value.
- eラーニングコースの世界市場2015-2019About Generic E-learning Course Materials and Related Services E-learning refers to learning facilitated with the help of gadgets such as PCs, notebooks, and tablets. E-learning is backed by ICT, which enables 24/7 learning for end-users from any access point. The curriculum of e-learning includes archived and real-time information, and there is no single standard e-learning method used in the Edu …
- 心電図装置（医療機器）のグローバル新興国市場（2012-2018）BRICSS Electrocardiogram (ECG) Devices market value is expected to reach US$64 million by 2016, primarily supported by the product types - Resting ECG and Stress ECG. China accounts for nearly 24% of the market share and India claims more than 24%. In terms of CAGR, India is the fastest growing region while China and Russia are just behind. Among the product types, Resting ECG accounts more nearly …
- 配電自動化システムの世界市場分析：実施方法別（変電所自動化、供給者自動化、消費者側自動化）、用途別）、地域別、セグメント予測、2014-2025The global electric power distribution automation systems market is expected to reach USD 23.7 billion by 2025, according to a new report conducted by Grand View Research, Inc. The rise in the adoption of smart grids & funding initiatives is projected to spur the demand for distribution automation systems. The growing investments in transmission & distribution are expected to remain a key driver. …
- 変圧器監視システムの世界市場予測：配電変圧器、電力変圧器The global transformer monitoring system market is projected to grow at a CAGR of 12.77% from 2016 to 2021, to reach a market size of USD 2.68 Billion by 2021. This growth is attributed to the digitalization of utilities, renewable investments, and smart grid initiatives. The report segments the transformer monitoring system market based on type into hardware solutions and IT solutions. The hardwa …
- 研削盤の世界市場2015-2019About Grinding Machines Grinding machines are tools used in the development of products with critical dimensions. They use an abrasive wheel as the tool for grinding. There are several types of grinding machines such as surface grinders, bench grinders, cylindrical grinders, tool and cutter grinders, jig grinders, gear grinders, profile grinders, and special purpose grinders. These grinders are ad …
